Drug Delivery Products

The best growth opportunities will emerge in dosage formulations that improve therapy for autoimmune conditions, cancer, heart disease, neurological disorders and other debilitating illnesses.

US demand to rise 7.4% annually through 2015

US demand for drug delivery products will expand 7.4 percent annually to $134 billion in 2015. The best growth opportunities will emerge in dosage formulations that advance the nature of therapy for autoimmune conditions, cancer, heart disease, neurological disorders and other debilitating health problems. Drug delivery devices with improved safety, infection prevention and ease-of-use features will also fare well in the marketplace. Based on the complex nature of therapy and the high frequency of dosing requirements, central nervous system and hormonal and related conditions will be the fastest growing indications served by drug delivery products.

Parenteral drug delivery products to grow fastest

Demand for oral drug delivery products will increase 4.3 percent annually to over $52 billion in 2015. Controlled-release formulations will command the largest share of sales, but will lose some growth momentum due to patent expirations on several large-selling sustained-release therapies. Nanoparticulate medicines will record some of the fastest growth among oral drug delivery products based on new products and the high value-added nature of indications served.

Demand for parenteral drug delivery products will reach $54.7 billion in 2015, up nearly eleven percent annually from 2010. Monoclonal antibodies will lead gains as advances in biotechnology lead to the introduction of new and improved therapies for autoimmune disorders, cancer and various rare debilitating diseases. Polymer-encapsulated medicines will also record fast rising demand based on contributions to the improved bioavailability and reduced toxicity of advanced parenteral compounds. Safety-engineered prefillable syringes and IV catheters, along with bag/vial infusion systems, will post the best growth among parenteral delivery devices based largely on infection prevention advantages.

Demand for other drug delivery products will rise 7.4 percent annually to $27.1 billion in 2010. Prefilled dry powder and metered dose inhalers will retain the largest share of sales, spurred by upward trends in prevalence of asthma and chronic obstructive pulmonary disease (COPD). However, growth for these devices will decelerate as patent expirations open up several widely prescribed inhalation therapies, including sales leader ADVAIR (GlaxoSmithKline), to generic competition.

Demand for implantable drug delivery products will increase nearly eleven percent annually through 2015 led by new brachytherapy offerings for cancer and macular degeneration. Additionally, the US market for drug-eluting stents will rebound from a recent downturn as next-generation devices with thinner struts and improved safety profiles promote expansion in the volume of angioplasty procedures.

Study Scope

This study analyzes the $93.8 billion US drug delivery system industry. It presents historical demand data for the years 2000, 2005 and 2010, and forecasts for 2015 and 2020 by excipient (e.g., polymers, cellulose, minerals), product type (e.g., oral, parenteral, inhalation, implantable, transdermal) and application (e.g., central nervous system, respiratory, hormones, gastrointestinal).

The study also considers market environment factors, details industry structure, evaluates company market share and profiles 27 industry players, including Roche, GlaxoSmithKline and Becton Dickinson.

Back to Top

Purchase Drug Delivery Products by the Section

  1. Drug Delivery Products

    $4,800.00

    1. 1 INTRODUCTION

      $95.00

    2. 2 EXECUTIVE SUMMARY

      $113.00

      1. Table | DRUG DELIVERY PRODUCT DEMAND BY TYPE & APPLICATION (million dollars)

    3. 3 MARKET ENVIRONMENT

      $1,435.00

      1. 3.1 General

        $82.00

      2. 3.2 Economic Factors

        $140.00

        1. Table | MACROECONOMIC INDICATORS

      3. 3.3 Demographic Patterns

        $110.00

        1. Table | POPULATION BY AGE GROUP (million persons)

      4. 3.4 Health Care Trends

        $614.00

        1. 3.4.1 Health Insurance

          $109.00

          1. Table | HEALTH INSURANCE COVERAGE OF THE US POPULATION (million enrollees)

        2. 3.4.2 Medical Conditions

          $162.00

          1. Table | ACUTE CONDITIONS BY TYPE (million conditions)

          2. Table | CHRONIC CONDITIONS BY TYPE (million conditions)

        3. 3.4.3 National Health Expenditures

          $85.00

          1. Table | NATIONAL HEALTH EXPENDITURES BY TYPE (billion dollars)

        4. 3.4.4 Medical Providers

          $113.00

          1. Table | MEDICAL PROVIDERS BY TYPE

        5. 3.4.5 Patient Activity

          $133.00

          1. Table | PATIENT ACTIVITY BY TYPE & VOLUME

      5. 3.5 Pharmaceutical Market Overview

        $519.00

        1. 3.5.1 Regulation

          $82.00

        2. 3.5.2 Research & Development

          $82.00

        3. 3.5.3 Demand Patterns

          $347.00

          1. Table | PHARMACEUTICAL DEMAND BY THERAPEUTIC CLASS (billion dollars)

          2. Table | PHARMACEUTICAL DEMAND BY DOSAGE FORMULATION (billion dollars)

          3. Table | PHARMACEUTICAL DEMAND BY DISTRIBUTION CLASSIFICATION (billion dollars)

          4. Table | PHARMACEUTICAL DEMAND BY COMMERCIAL STATUS (billion dollars)

    4. 4 DRUG DELIVERY EXCIPIENTS

      $1,025.00

      1. 4.1 General

        $82.00

        1. Table | DRUG DELIVERY EXCIPIENT DEMAND BY PRODUCT GROUP (million dollars)

      2. 4.2 Polymers

        $297.00

        1. Table | POLYMER DRUG DELIVERY EXCIPIENT DEMAND BY TYPE (million dollars)

        2. 4.2.1 Polyethylene Glycol

          $82.00

        3. 4.2.2 Acrylic Polymers

          $96.00

        4. 4.2.3 Polyethylene Oxide

          $82.00

        5. 4.2.4 Polyvinyl Alcohol

          $82.00

        6. 4.2.5 Other Synthetic Polymers

          $82.00

      3. 4.3 Cellulose Excipients

        $147.00

        1. Table | CELLULOSE DRUG DELIVERY EXCIPIENT DEMAND BY TYPE (million dollars)

        2. 4.3.1 Ethyl Cellulose

          $82.00

        3. 4.3.2 Hydroxypropyl Methylcellulose (HPMC)

          $82.00

        4. 4.3.3 Other Cellulose Excipients

          $82.00

      4. 4.4 Minerals

        $204.00

        1. Table | MINERAL DRUG DELIVERY EXCIPIENT DEMAND BY TYPE (million dollars)

        2. 4.4.1 Mineral Hydrocarbons

          $91.00

        3. 4.4.2 Other Minerals

          $95.00

      5. 4.5 Other Excipients

        $321.00

        1. Table | OTHER DRUG DELIVERY EXCIPIENT DEMAND BY TYPE (million dollars)

        2. 4.5.1 Sterile & Purified Waters

          $82.00

        3. 4.5.2 Starch Compounds

          $82.00

        4. 4.5.3 Sugars & Polyols

          $113.00

        5. 4.5.4 Natural Gums

          $82.00

        6. 4.5.5 All Other Excipients

          $82.00

    5. 5 DRUG DELIVERY PRODUCTS OVERVIEW

      $457.00

      1. 5.1 General

        $82.00

        1. Table | DRUG DELIVERY PRODUCT DEMAND BY DOSAGE FORMULATION (million dollars)

      2. 5.2 Types of Drug Delivery Products

        $94.00

      3. 5.3 Historical Market Trends

        $98.00

        1. Table | DRUG DELIVERY PRODUCT DEMAND, 2000-2010

      4. 5.4 Regulation

        $82.00

      5. 5.5 Research & Development

        $82.00

      6. 5.6 US Trade

        $82.00

        1. Table | US TRADE IN DRUG DELIVERY PRODUCTS (million dollars)

      7. 5.7 International Markets

        $82.00

        1. Table | WORLD DRUG DELIVERY PRODUCT DEMAND BY REGION (million dollars)

    6. 6 ORAL DRUG DELIVERY PRODUCTS

      $870.00

      1. 6.1 General

        $82.00

        1. Table | ORAL DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      2. 6.2 Controlled-Release Formulations

        $362.00

        1. Table | ORAL CONTROLLED-RELEASE DRUG DELIVERY PRODUCT DEMAND BY TYPE, MODE OF ACTION & APPLICATION (million dollars)

        2. 6.2.1 Coated Products

          $119.00

          1. Table | ORAL COATED DRUG DELIVERY PRODUCT DEMAND (million dollars)

        3. 6.2.2 Diffusion Products

          $82.00

          1. Table | ORAL DIFFUSION DRUG DELIVERY PRODUCT DEMAND (million dollars)

        4. 6.2.3 Reservoir Products

          $82.00

          1. Table | ORAL RESERVOIR DRUG DELIVERY PRODUCT DEMAND (million dollars)

      3. 6.3 Chewable Tablets

        $93.00

        1. Table | CHEWABLE TABLET DEMAND BY THERAPEUTIC CLASS (million dollars)

      4. 6.4 Nanoparticulate Formulations

        $118.00

        1. Table | ORAL NANOPARTICULATE PRODUCT DEMAND BY APPLICATION (million dollars)

      5. 6.5 Orally Disintegrating Tablets (ODT)

        $113.00

        1. Table | ORALLY DISINTEGRATING TABLET (ODT) DEMAND BY APPLICATION (million dollars)

      6. 6.6 Transmucosal Formulations

        $112.00

        1. Table | TRANSMUCOSAL PRODUCT DEMAND (million dollars)

    7. 7 PARENTERAL DRUG DELIVERY PRODUCTS

      $2,458.00

      1. 7.1 General

        $82.00

        1. Table | PARENTERAL DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      2. 7.2 Therapeutic Monoclonal Antibodies

        $1,141.00

        1. Table | THERAPEUTIC MONOCLONAL ANTIBODY DEMAND BY APPLICATION (million dollars)

        2. 7.2.1 Types of Monoclonal Antibodies

          $82.00

        3. 7.2.2 Marketed Products

          $764.00

          1. Table | THERAPEUTIC MONOCLONAL ANTIBODIES APPROVED FOR US SALE

        4. 7.2.3 Therapeutic Monoclonal Antibodies in Development

          $237.00

      3. 7.3 Encapsulated Parenteral Drug Delivery Products

        $468.00

        1. Table | ENCAPSULATED PARENTERAL PRODUCT DEMAND BY TYPE & APPLICATION (million dollars)

        2. 7.3.1 Polymer-Protected Products

          $305.00

        3. 7.3.2 Liposomes

          $132.00

      4. 7.4 Infusion Products

        $323.00

        1. Table | INFUSION PRODUCT DEMAND BY TYPE (million dollars)

        2. 7.4.1 IV Administration Sets

          $82.00

        3. 7.4.2 Premixed IV Solutions

          $82.00

        4. 7.4.3 Infusion Pumps

          $82.00

        5. 7.4.4 Other Infusion Products

          $88.00

      5. 7.5 Parenteral Drug Delivery Devices

        $455.00

        1. Table | PARENTERAL DELIVERY DEVICE DEMAND BY TYPE (million dollars)

        2. 7.5.1 Prefillable Syringes

          $232.00

        3. 7.5.2 Hypodermic Syringes

          $82.00

        4. 7.5.3 IV Catheters

          $82.00

        5. 7.5.4 Other Parenteral Delivery Devices

          $82.00

    8. 8 OTHER DRUG DELIVERY PRODUCTS

      $1,232.00

      1. 8.1 General

        $82.00

        1. Table | OTHER DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      2. 8.2 Inhalation Drug Delivery Products

        $334.00

        1. Table | INHALATION DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

        2. 8.2.1 Dry Powder Formulations

          $128.00

          1. Table | DRY POWDER INHALER (DPI) PRODUCT DEMAND (million dollars)

        3. 8.2.2 Metered Dose Formulations

          $169.00

          1. Table | METERED DOSE INHALER (MDI) PRODUCT DEMAND (million dollars)

      3. 8.3 Implantable Drug Delivery Products

        $461.00

        1. Table | IMPLANTABLE DRUG DELIVERY PRODUCT DEMAND BY TYPE & APPLICATION (million dollars)

        2. 8.3.1 Drug-Eluting Stents

          $135.00

          1. Table | DRUG-ELUTING STENT DEMAND (million dollars)

        3. 8.3.2 Other Implantable Drug Delivery Products

          $281.00

          1. Table | OTHER IMPLANTABLE DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      4. 8.4 Transdermal Drug Delivery Products

        $374.00

        1. Table | TRANSDERMAL PRODUCT DEMAND BY APPLICATION (million dollars)

        2. 8.4.1 Transdermal Technologies

          $82.00

        3. 8.4.2 Central Nervous System Agents

          $94.00

        4. 8.4.3 Other Transdermal Therapies

          $179.00

    9. 9 APPLICATIONS

      $1,009.00

      1. 9.1 General

        $82.00

        1. Table | DRUG DELIVERY PRODUCT DEMAND BY APPLICATION (million dollars)

      2. 9.2 Central Nervous System Agents

        $132.00

        1. Table | CENTRAL NERVOUS SYSTEM (CNS) DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      3. 9.3 Respiratory Agents

        $103.00

        1. Table | RESPIRATORY DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      4. 9.4 Hormones & Related Agents

        $201.00

        1. Table | HORMONE & RELATED DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      5. 9.5 Gastrointestinal Agents

        $82.00

        1. Table | GASTROINTESTINAL DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      6. 9.6 Cardiovascular Agents

        $141.00

        1. Table | CARDIOVASCULAR DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      7. 9.7 Anti-Infective Agents

        $82.00

        1. Table | ANTI-INFECTIVE DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      8. 9.8 Nutritional Agents

        $82.00

        1. Table | NUTRITIONAL DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      9. 9.9 Genito-Urinary Agents

        $82.00

        1. Table | GENITO-URINARY DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars)

      10. 9.10 Other Pharmaceuticals

        $133.00

        1. Table | DRUG DELIVERY PRODUCT DEMAND IN OTHER PHARMACEUTICALS BY TYPE (million dollars)

    10. 10 INDUSTRY STRUCTURE

      $4,761.00

      1. 10.1 General

        $82.00

        1. Table | US DRUG DELIVERY PRODUCT SALES BY COMPANY, 2010 (million dollars)

      2. 10.2 Market Share

        $84.00

      3. 10.3 Competitive Strategies

        $82.00

      4. 10.4 Mergers & Acquisitions

        $121.00

        1. Table | SELECTED ACQUISITIONS & DIVESTITURES

      5. 10.5 Licensing & Related Agreements

        $164.00

        1. Table | SELECTED COOPERATIVE AGREEMENTS

      6. 10.6 Marketing & Distribution

        $82.00

      7. 10.7 Manufacturing

        $82.00

      8. 10.8 Company Profiles

        $4,163.00

        1. 10.8.1 Abbott Laboratories

          $183.00

        2. 10.8.2 Amgen Incorporated

          $121.00

        3. 10.8.3 Aptalis Pharma Incorporated

          $217.00

        4. 10.8.4 AptarGroup Incorporated

          $115.00

        5. 10.8.5 AstraZeneca plc

          $169.00

        6. 10.8.6 Baxter International Incorporated

          $137.00

        7. 10.8.7 Becton, Dickinson and Company

          $282.00

        8. 10.8.8 Boehringer Ingelheim GmbH

          $113.00

        9. 10.8.9 Boston Scientific Corporation

          $82.00

        10. 10.8.10 Braun (B.) Melsungen AG

          $134.00

        11. 10.8.11 Bristol-Myers Squibb Company

          $108.00

        12. 10.8.12 Evonik Industries AG

          $111.00

        13. 10.8.13 GlaxoSmithKline plc

          $175.00

        14. 10.8.14 Hospira Incorporated

          $250.00

        15. 10.8.15 Johnson & Johnson

          $235.00

        16. 10.8.16 Lilly (Eli) and Company

          $155.00

        17. 10.8.17 Merck & Company Incorporated

          $187.00

        18. 10.8.18 Nitto Denko Corporation

          $116.00

        19. 10.8.19 Novartis AG

          $179.00

        20. 10.8.20 Novo Nordisk A/S

          $82.00

        21. 10.8.21 Pfizer Incorporated

          $111.00

        22. 10.8.22 Roche Holding Limited

          $181.00

        23. 10.8.23 Sanofi-Aventis

          $220.00

        24. 10.8.24 Teva Pharmaceutical Industries Limited

          $143.00

        25. 10.8.25 3M Company

          $152.00

        26. 10.8.26 Unilife Corporation

          $132.00

        27. 10.8.27 West Pharmaceutical Services Incorporated

          $104.00

Back to Top